Blog
Germany Fast-Track Pathway for Early Clinical Development
Germany has significantly improved the attractiveness of early clinical development through the Medical Research Act (Medizinforschungsgesetz, MFG) to expedite the approval of mononational clinical trials. Sponsors conducting innovative studies in Germany can benefit from accelerated regulatory processes, streamlined ethics review,...